Breast cancer pharmacotherapy and imaging interpretation: pathophysiological perspectives and clinical application

Modern breast cancer treatment has evolved significantly, integrating advanced imaging techniques and a variety of drug therapies, including endocrine therapy, chemotherapy, molecularly targeted drugs, and immune checkpoint inhibitors. This study discusses the interplay of drug treatments and imaging diagnostics in optimizing patient outcomes. Key findings emphasize the importance of personalized treatments based on intrinsic subtypes and imaging-guided decisions, as well as the management of treatment-related adverse effects.